FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2542-2544 December 9, 2004 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Hohnloser, S. H. PubMed Citation

On September 28, 2004, the Centers for Medicare and Medicaid Services (CMS) proposed new reimbursement guidelines for implantable cardioverter–defibrillators (ICDs) used for the prevention of sudden death from cardiac causes. The new guidelines dramatically increase the number of patients for whom prophylactic implantation of an ICD would be covered by Medicare. Among other things, the CMS dispensed with the controversial "QRS restriction" on patients like those who participated in the second Multicenter Automatic Defibrillator Implantation Trial — so-called MADIT-II patients. In this trial, which was reported in the Journal in 2002, ICD therapy conferred a striking survival benefit as compared . . . [Full Text of this Article]

Source Information

From the Division of Cardiology, Long Island Jewish Medical Center, New Hyde Park, N.Y.

This article has been cited by other articles:

• Morpeth, S., Murdoch, D., Cabell, C. H., Karchmer, A. W., Pappas, P., Levine, D., Nacinovich, F., Tattevin, P., Fernandez-Hidalgo, N., Dickerman, S., Bouza, E., del Rio, A., Lejko-Zupanc, T., de Oliveira Ramos, A., Iarussi, D., Klein, J., Chirouze, C., Bedimo, R., Corey, G. R., Fowler, V. G. Jr., the International Collaboration on Endocarditis Pr, (2007). Non-HACEK Gram-Negative Bacillus Endocarditis. ANN INTERN MED 147: 829-835 [Abstract] [Full Text]  
• Couderc, J.-P., Zareba, W., McNitt, S., Maison-Blanche, P., Moss, A. J. (2007). Repolarization variability in the risk stratification of MADIT II patients. Europace 9: 717-723 [Abstract] [Full Text]  
• Chugh, S. S., Reinier, K., Stecker, E. C. (2007). Learning From a Real-World Analysis of Implantable Cardioverter-Defibrillator Recipients: Comorbidities Matter. J Am Coll Cardiol 49: 2416-2418 [Full Text]  
• Zimetbaum, P. J. (2007). A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator. JAMA 297: 1909-1916 [Abstract] [Full Text]  
• Fisher, J. D. (2005). Who Needs a Defibrillator?: The Beat Goes On. J Am Coll Cardiol 46: 1727-1728 [Full Text]  
• Neumann, P. J., Rosen, A. B., Weinstein, M. C. (2005). Medicare and Cost-Effectiveness Analysis. NEJM 353: 1516-1522 [Full Text]  
• Goldberger, Z., Elbel, B., McPherson, C. A., Paltiel, A. D., Lampert, R. (2005). Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation. J Am Coll Cardiol 46: 850-857 [Abstract] [Full Text]  
• Authors/Task Force Members, , Swedberg, K., Writing Committee:, , Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Other Contributors, , Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J.-L., Nieminen, M. S., Pierard, L., Remme, W. J. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140 [Full Text]  
• Pauker, S. G., Estes, N. A. M., Salem, D. N. (2005). Preventing Sudden Cardiac Death: Can We Afford the Benefit?. ANN INTERN MED 142: 664-666 [Full Text]